These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8049611)

  • 21. Reliability of self-reported use of amphetamine, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, and opiates among acutely hospitalized elderly medical patients.
    Glintborg B; Olsen L; Poulsen H; Linnet K; Dalhoff K
    Clin Toxicol (Phila); 2008 Mar; 46(3):239-42. PubMed ID: 18344106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine.
    Foltz RL; Botelho C; Reuschel SA; Kuntz DJ; Moody DE; Bristow GM
    NIDA Res Monogr; 1997; 175():287-302. PubMed ID: 9467805
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening for drugs of abuse (II): Cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs.
    Simpson D; Braithwaite RA; Jarvie DR; Stewart MJ; Walker S; Watson IW; Widdop B
    Ann Clin Biochem; 1997 Sep; 34 ( Pt 5)():460-510. PubMed ID: 9293303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
    Käferstein H; Sticht G
    Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
    Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
    J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine drug screening: practical guide for clinicians.
    Moeller KE; Lee KC; Kissack JC
    Mayo Clin Proc; 2008 Jan; 83(1):66-76. PubMed ID: 18174009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of random drug testing in an adolescent substance abuse program.
    Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR
    Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study.
    Marquet P; Delpla PA; Kerguelen S; Bremond J; Facy F; Garnier M; Guery B; Lhermitte M; Mathé D; Pelissier AL; Renaudeau C; Vest P; Seguela JP
    J Forensic Sci; 1998 Jul; 43(4):806-11. PubMed ID: 9670503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood-positive illicit-drug findings: implications for cause-of-death certification, classification and coding.
    Lahti RA; Korpi H; Vuori E
    Forensic Sci Int; 2009 May; 187(1-3):14-8. PubMed ID: 19303228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
    Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ
    J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.
    Krasowski MD; Pizon AF; Siam MG; Giannoutsos S; Iyer M; Ekins S
    BMC Emerg Med; 2009 Apr; 9():5. PubMed ID: 19400959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity.
    Tomaszewski C; Runge J; Gibbs M; Colucciello S; Price M
    J Emerg Med; 2005 May; 28(4):389-94. PubMed ID: 15837018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug analytics in oral fluid using immunoassay].
    Dierich O; Soyka M
    Fortschr Neurol Psychiatr; 2005 Jul; 73(7):401-8. PubMed ID: 16012919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of three commercial tests for buprenorphine screening in urine.
    Leino A; Loo BM
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):563-5. PubMed ID: 17961313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A semiautomated radioimmunoassay for mass screening of drugs of abuse.
    Sulkowski TS; Lathrop GD; Merritt JH; Landez JH; Noe ER
    J Forensic Sci; 1975 Jul; 20(3):524-36. PubMed ID: 1151310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Workshop on the detection and control of abuse of narcotics, barbiturates, and amphetamines; San Juan, Puerto Rico, December 13-15, 1965.
    Leonard F
    Psychopharmacol Bull; 1966 Dec; 3(4):21-6. PubMed ID: 5981117
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug abuse tests important part of preventive measures against narcotics. With testing drug abuse can be identified early in the workplace].
    Hermansson U; Beck O; Westregård A; Brunes M
    Lakartidningen; 2010 Nov 17-23; 107(46):2878-80. PubMed ID: 21197782
    [No Abstract]   [Full Text] [Related]  

  • 38. Experience of a laboratory service for drug screening in urine.
    Simpson D; Greenwood J; Jarvie DR; Moore FM
    Scott Med J; 1993 Feb; 38(1):20-6. PubMed ID: 8451622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homogenous immunochemical drug assays.
    Bastiani RJ; Phillips RC; Schneider RS; Ullman EF
    Am J Med Technol; 1973 Jun; 39(6):211-6. PubMed ID: 4350742
    [No Abstract]   [Full Text] [Related]  

  • 40. Positive predictive values of abused drug immunoassays on the Beckman Synchron in a veteran population.
    Dietzen DJ; Ecos K; Friedman D; Beason S
    J Anal Toxicol; 2001 Apr; 25(3):174-8. PubMed ID: 11327349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.